Profile
Dr. Bobby Gaspar is a Chief Executive Officer & Director at Orchard Therapeutics (Europe) Ltd., a Chief Executive Officer at Orchard Therapeutics Plc, a Chief Executive Officer at Orchard Therapeutics North America and a Venture Partner at Impresa Management LLC (United Kingdom).
He is on the Board of Directors at Alliance for Regenerative Medicine, Centre For Research In Rare Diseases In Children and Orchard Therapeutics (Europe) Ltd.
Dr. Gaspar was previously employed as a Professor by UCL Institute of Child Health.
He received his graduate degree from King's College London and a doctorate degree from the University College London.
Bobby Gaspar active positions
| Companies | Position | Start |
|---|---|---|
| ORCHARD THERAPEUTICS PLC | Chief Executive Officer | 2020-03-17 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Founder | 2015-01-01 |
Centre For Research In Rare Diseases In Children | Director/Board Member | 2017-12-31 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Board Member | 2020-12-31 |
Orchard Therapeutics North America
Orchard Therapeutics North America BiotechnologyHealth Technology Provides biotechnology research services | Chief Executive Officer | - |
Impresa Management LLC (United Kingdom)
Impresa Management LLC (United Kingdom) Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | - |
Former positions of Bobby Gaspar
| Companies | Position | End |
|---|---|---|
UCL Institute of Child Health | Corporate Officer/Principal | 2020-02-29 |
Training of Bobby Gaspar
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
UCL Institute of Child Health | |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Impresa Management LLC (United Kingdom)
Impresa Management LLC (United Kingdom) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Centre For Research In Rare Diseases In Children | |
Orchard Therapeutics North America
Orchard Therapeutics North America BiotechnologyHealth Technology Provides biotechnology research services | Health Technology |
- Stock Market
- Insiders
- Bobby Gaspar
















